OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 44 filers reported holding OYSTER PT PHARMA INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 3.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,689,000 | +54.1% | 92,500 | 0.0% | 0.02% | +63.6% |
| Q3 2021 | $1,096,000 | -31.1% | 92,500 | 0.0% | 0.01% | -15.4% |
| Q2 2021 | $1,590,000 | -6.0% | 92,500 | 0.0% | 0.01% | -18.8% |
| Q1 2021 | $1,691,000 | -2.9% | 92,500 | 0.0% | 0.02% | -23.8% |
| Q4 2020 | $1,741,000 | -8.4% | 92,500 | +2.8% | 0.02% | -16.0% |
| Q3 2020 | $1,900,000 | -26.9% | 90,000 | 0.0% | 0.02% | -45.7% |
| Q2 2020 | $2,599,000 | +271.3% | 90,000 | +350.0% | 0.05% | +283.3% |
| Q1 2020 | $700,000 | +175.6% | 20,000 | +92.3% | 0.01% | +200.0% |
| Q4 2019 | $254,000 | – | 10,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 2,768,586 | $15,559,000 | 8.54% |
| NEA Management Company, LLC | 5,925,287 | $33,300,000 | 1.66% |
| KPCB XIV Associates, LLC | 367,987 | $2,068,000 | 1.61% |
| Paradigm Biocapital Advisors LP | 1,648,316 | $9,264,000 | 1.24% |
| Telemark Asset Management, LLC | 777,026 | $4,367,000 | 0.69% |
| COWEN AND COMPANY, LLC | 509,794 | $2,865,000 | 0.27% |
| RTW INVESTMENTS, LP | 2,044,312 | $11,489,000 | 0.26% |
| Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $5,843,000 | 0.12% |
| Wildcat Capital Management, LLC | 36,847 | $207,000 | 0.08% |
| ACT CAPITAL MANAGEMENT, LLC | 8,500 | $48,000 | 0.07% |